We read with great interest the article by Calligaro et al (J Vasc Surg 2003;38:1170-7) describing their experiences with acute arterial complications related to hip and knee arthroplasty. We find one major point of concern in their work. The authors stated that "patients did not receive routinely anticoagulation therapy" after urgent vascular surgery performed in those patients developing signs of acute arterial complications shortly after arthroplasty. Although the question of routine thromboprophylaxis after major orthopedic surgery has been raised before 1 and is also an issue of debate in vascular surgery, 2,3 current guidelines still recommend some form of prophylaxis to be used in such patients. Since in patients undergoing lower extremity arthroplasty, an intense activation of the clotting cascade 4 is associated with venous stasis and endothelial injury caused by kinking of the femoral vein during intraoperative lower extremity manipulation, these patients are at high risk for venous thromboembolism. 5 The use of a tourniquet during total knee arthroplasty is an additional risk factor. Subsequent vascular surgery can only heighten the risk for venous thromboembolism in such patients.Although thromboprophylaxis was not a focus of their work, the authors should have clearly stated on what grounds they chose to go against current guidelines and omit postoperative anticoagulation in such high-risk patients. It should also have been noted whether their patients received some other form of thromboprophylaxis (eg, intermittent pneumatic compression) and how early passive and active limb mobilization was begun. These are points crucial to any patient undergoing total hip or knee arthroplasty.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.